Home » Team Members » Matt Best

Matt Best

Head of Internal Medicine

When Matt joined Eastcott in 2019 he brought with him a particular interest in medical oncology.  Matt worked at Brisbane Veterinary Specialist Centre in Australia for 7 years, including his residency, and at the time they were the only centre in the Southern hemisphere with a veterinary linear accelerator (radiation therapy machine) ensuring that he enjoyed a large and exciting oncology case load. During and since this time Matt has had a large oncology case load and has continued with clinical research into cancer in pets.  His biggest contribution to veterinary oncology to date came with the publication of a study into the treatment of lymphoma in dogs with radiation therapy – since this paper there has been a resurgence in the use of this treatment across the world for dogs with lymphoma.

At Eastcott the oncology service has been early in the adoption of the latest oncologic techniques and best practice including routine use of sentinel lymph node studies for staging and the development of an electrochemotherapy service opening a low side effect option for a number of tumours in dogs and cats.  Matt enjoys all types of medical oncology as well as the chance to work closely with his colleagues to provide holistic specialist care including soft tissue surgery, maxillofacial surgery, imaging, anaesthesia, pain management and physiotherapy.

Best MP & Fry DR, 2013. Incidence of sterile hemorrhagic cystitis in dogs receiving cyclophosphamide orally for three days without concurrent furosemide as part a chemotherapeutic treatment for lymphoma : 57 cases (2007-2012). J Am Vet Med Assoc 243(7): 1025-9.

Best MP & Frimberger AE, 2017. Ovarian carcinomatosis in a dog managed with surgery and intraperitoneal, systemic and intrapleural and systemic chemotherapy utilising indwelling pleural access ports. Can Vet J 58:493-497.

Danesi P, Ravagnan S, Johnson L, Furlanello T, Milani A, Martin P, Boyd S, Best M, Galgut B, Irwin P, Canfield P, Krockenberger B, Halliday C, Meyer W & Malik R, 2017. The molecular diagnosis of Pneumocystis canis pneumonia in dogs. Medical Mycology 55(8):828-842.

Best MP, Danesi P & Boyd SP, 2019. A confirmed case of Pneumocystis pneumonia in a Maltese X Papillion dog being treated with toceranib phosphate. Aus Vet Journal 97(5):162-165.

Walton-Clark M, Travail V & Best M, 2022. Phenobarbital-induced autoimmune haemolytic anaemia, thrombocytopaenia and peripheral lymphadenomegaly due to reactive lymphoid hyperplasia in a cat.  Journal of Feline Medicine and Surgery Open Reports 2022

Best MP, Straw RC, Gumpel E & Fry DR, 2023. Long-term remission and survival in dogs with high-grade, B cell lymphoma treated with chemotherapy with or without sequential low-dose rate half-body irradiation.  Journal of Veterinary Internal Medicine 37(6): 2368-2374

Matt-Best-team-profile-resized

Head of Internal Medicine, RCVS Specialist in Small Animal Medicine